Cat. #162306
Glioblastoma WHO IV NCH82 cell line
Cat. #: 162306
Organism: Human
Tissue: Brain
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Christel Herold-Mende
Institute: Heidelberg University
Primary Citation: Karcher et al. 2005. Cancer Cell Biol. 118(9):2182-2189. PMID: 16331629.
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Glioblastoma WHO IV NCH82 cell line
- Cancer: Brain
- Organism: Human
- Tissue: Brain
- Growth properties: Mixed - adherent and suspension
- Description: Glioblastoma WHO IV cell line, NCH82
- Biosafety level: 2
Handling
- Growth medium: DMEM supplemented with 10% fetal calf serum + 1% penicillin/streptomycin
- Temperature: 37°C
- Atmosphere: 5% CO2
References
- Arseni et al. 2023. Cancers. 15(2):479. PMID: 36672428.
- Fermi et al. 2022. Chemistry. 28(34):e202104535. PMID: 35293640.
- Wirthschaft et al. 2019. Acta Neuropathol. 138(2):275-293. PMID: 31062076.
- Jortzik et al. 2014. Biochimica et Biophysica Acta. 1844(8):1415-1426. PMID: 24440405.
- Schüle et al. 2012. Scientific World Journal. 2012:697313. PMID: 22919349.
- Dokic et al. 2012. Glia. 60(11):1785-1800. PMID: 22951908.
- Campos et al. 2011. Am J Pathol. 178(5):1953-1964. PMID: 21514413.
- Konkarevic et al. 2009. Free Radic Biol Med. 46(8):1096-108. PMID: 19439228.
- Siegelin et al. 2008. Mol Cancer Ther. 7(11):3566-3574, PMID: 19001439.
- Gdynia et al. 2007. Mol Cancer Res. 5(12):1232-1240. PMID: 18171980.
- Karcher et al. 2005. Cancer Cell Biol. 118(9):2182-2189. PMID: 16331629.
- Steiner et al. 2004. J Neurooncol. 66(1-2):129-138. PMID: 15015778.
